Search

Your search keyword '"Martin, Scott E."' showing total 501 results
Start Over Author "Martin, Scott E."
501 results on '"Martin, Scott E."'

2. ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma

Author

Yen, Ivana, Shanahan, Frances, Lee, Jeeyun, Hong, Yong Sang, Shin, Sang Joon, Moore, Amanda R., Sudhamsu, Jawahar, Chang, Matthew T., Bae, Inhwan, Dela Cruz, Darlene, Hunsaker, Thomas, Klijn, Christiaan, Liau, Nicholas P.D., Lin, Eva, Martin, Scott E., Mondrusan, Zora, and Piskol, Robert

Subjects
Antineoplastic agents -- Dosage and administration, Mutation (Biology) -- Health aspects, Protein kinases -- Physiological aspects, Melanoma -- Genetic aspects -- Drug therapy, Antimitotic agents -- Dosage and administration, Environmental issues, Science and technology, Zoology and wildlife conservation
Abstract

Although RAF monomer inhibitors (type I.5, BRAF(V600)) are clinically approved for the treatment of BRAF.sup.V600-mutant melanoma, they are ineffective in non-BRAF.sup.V600 mutant cells.sup.1-3. Belvarafenib is a potent and selective RAF dimer (type II) inhibitor that exhibits clinical activity in patients with BRAF.sup.V600E- and NRAS-mutant melanomas. Here we report the first-in-human phase I study investigating the maximum tolerated dose, and assessing the safety and preliminary efficacy of belvarafenib in BRAF.sup.V600E- and RAS-mutated advanced solid tumours (NCT02405065, NCT03118817). By generating belvarafenib-resistant NRAS-mutant melanoma cells and analysing circulating tumour DNA from patients treated with belvarafenib, we identified new recurrent mutations in ARAF within the kinase domain. ARAF mutants conferred resistance to belvarafenib in both a dimer- and a kinase activity-dependent manner. Belvarafenib induced ARAF mutant dimers, and dimers containing mutant ARAF were active in the presence of inhibitor. ARAF mutations may serve as a general resistance mechanism for RAF dimer inhibitors as the mutants exhibit reduced sensitivity to a panel of type II RAF inhibitors. The combination of RAF plus MEK inhibition may be used to delay ARAF-driven resistance and suggests a rational combination for clinical use. Together, our findings reveal specific and compensatory functions for the ARAF isoform and implicate ARAF mutations as a driver of resistance to RAF dimer inhibitors. The development, characterization and phase I clinical testing of the RAF inhibitor belvarafenib in cancer and a new resistance mechanism mediated by ARAF mutations are described., Author(s): Ivana Yen [sup.1] , Frances Shanahan [sup.1] , Jeeyun Lee [sup.2] [sup.3] , Yong Sang Hong [sup.4] , Sang Joon Shin [sup.5] , Amanda R. Moore [sup.1] , Jawahar [...]

Published
2021
Full Text
View/download PDF

3. Enhanced Functional Genomic Screening Identifies Novel Mediators of Dual Leucine Zipper Kinase-Dependent Injury Signaling in Neurons

Author

Welsbie, Derek S, Mitchell, Katherine L, Jaskula-Ranga, Vinod, Sluch, Valentin M, Yang, Zhiyong, Kim, Jessica, Buehler, Eugen, Patel, Amit, Martin, Scott E, Zhang, Ping-Wu, Ge, Yan, Duan, Yukan, Fuller, John, Kim, Byung-Jin, Hamed, Eman, Chamling, Xitiz, Lei, Lei, Fraser, Iain DC, Ronai, Ze’ev A, Berlinicke, Cynthia A, and Zack, Donald J

Subjects
Biomedical and Clinical Sciences, Neurosciences, Genetics, Biotechnology, Stem Cell Research - Embryonic - Human, Human Genome, Stem Cell Research, Aetiology, 2.1 Biological and endogenous factors, Underpinning research, 1.1 Normal biological development and functioning, Animals, Cell Death, Cell Survival, Disease Models, Animal, Flow Cytometry, Human Embryonic Stem Cells, Humans, Immunoprecipitation, MAP Kinase Kinase Kinases, Mice, Mice, Knockout, Neurites, Neurons, Optic Nerve Injuries, Piperazines, Protein Kinase Inhibitors, Real-Time Polymerase Chain Reaction, Retina, Retinal Ganglion Cells, DLK, LZK, Neuroprotection, RGC, RNAi screen, cell death signaling, glaucoma, Psychology, Cognitive Sciences, Neurology & Neurosurgery, Biological psychology
Abstract

Dual leucine zipper kinase (DLK) has been implicated in cell death signaling secondary to axonal damage in retinal ganglion cells (RGCs) and other neurons. To better understand the pathway through which DLK acts, we developed enhanced functional genomic screens in primary RGCs, including use of arrayed, whole-genome, small interfering RNA libraries. Explaining why DLK inhibition is only partially protective, we identify leucine zipper kinase (LZK) as cooperating with DLK to activate downstream signaling and cell death in RGCs, including in a mouse model of optic nerve injury, and show that the same pathway is active in human stem cell-derived RGCs. Moreover, we identify four transcription factors, JUN, activating transcription factor 2 (ATF2), myocyte-specific enhancer factor 2A (MEF2A), and SRY-Box 11 (SOX11), as being the major downstream mediators through which DLK/LZK activation leads to RGC cell death. Increased understanding of the DLK pathway has implications for understanding and treating neurodegenerative diseases.

Published
2017

4. Targeting the Hippo pathway in cancers via ubiquitination dependent TEAD degradation

Author

Pham, Trang H, primary, Pahuja, Kanika Bajaj, additional, Hagenbeek, Thijs J, additional, Zbieg, Jason, additional, Noland, Cameron L, additional, Pham, Victoria C, additional, Yao, Xiaosai, additional, Rose, Christopher M, additional, Browder, Kristen C, additional, Lee, Ho-June, additional, Yu, Mamie, additional, Liang-Chu, May, additional, Martin, Scott E, additional, Verschueren, Erik, additional, Li, Jason, additional, Kubala, Marta H, additional, Fong, Rina, additional, Lorenzo, Maria, additional, Beroza, Paul, additional, Hsu, Peter, additional, Paul, Sayantanee, additional, Villemure, Elisia, additional, Lee, Wendy, additional, Cheung, Tommy, additional, Clausen, Saundra, additional, Lacap, Jennifer, additional, Liang, Yuxin, additional, Cheng, Jason, additional, Schmidt, Steve, additional, Modrusan, Zora, additional, Cohen, Michael S, additional, Crawford, James, additional, Jasper, Heinrich, additional, Ashworth, Alan, additional, Lill, Jennie R, additional, Malek, Shiva, additional, Rudolph, Joachim, additional, Wertz, Ingrid E, additional, Chang, Matthew, additional, Ye, Xin, additional, and Dey, Anwesha, additional

Published
2023
Full Text
View/download PDF

5. Correlates of persistent smoking in bars subject to smokefree workplace policy.

Author

Moore, Roland S, Lee, Juliet P, Martin, Scott E, Todd, Michael, and Chu, Bong Chul

Subjects
Humans, Logistic Models, Smoking, Workplace, San Francisco, Female, Male, Smokefree workplace policy, bars, smoking behavior, tobacco control, Tobacco Smoke and Health, Basic Behavioral and Social Science, Tobacco, Prevention, Behavioral and Social Science, Smoking and Health, Toxicology
Abstract

This study's goal was to characterize physical and social environments of stand-alone bars associated with indoor smoking despite California's smokefree workplace law. In a random sample of 121 stand-alone bars in San Francisco, trained observers collected data on patrons, staff, neighborhood, indoor settings and smoking behaviors. Using bivariate (chi-square) and hierarchical linear modeling analyses, we identified four correlates of patrons' indoor smoking: 1) bars serving predominantly Asian or Irish patrons, 2) ashtrays, 3) bartender smoking, and 4) female bartenders. Public health officials charged with enforcement of smokefree bar policies may need to attend to social practices within bars, and heighten perceptions of consistent enforcement of smokefree workplace laws.

Published
2009

7. Figure S5 from Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling

Author

Li, Dandan, primary, Miermont, Anne M., primary, Sable, Rushikesh, primary, Quadri, Humair S., primary, Mathews Griner, Lesley A., primary, Martin, Scott E., primary, Odzorig, Taivan, primary, De, Soumita, primary, Ferrer, Marc, primary, Powers, Astin S., primary, Hewitt, Stephen M., primary, and Rudloff, Udo, primary

Published
2023
Full Text
View/download PDF

8. Data from Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling

Author

Li, Dandan, primary, Miermont, Anne M., primary, Sable, Rushikesh, primary, Quadri, Humair S., primary, Mathews Griner, Lesley A., primary, Martin, Scott E., primary, Odzorig, Taivan, primary, De, Soumita, primary, Ferrer, Marc, primary, Powers, Astin S., primary, Hewitt, Stephen M., primary, and Rudloff, Udo, primary

Published
2023
Full Text
View/download PDF

9. Table S1 from Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling

Author

Li, Dandan, primary, Miermont, Anne M., primary, Sable, Rushikesh, primary, Quadri, Humair S., primary, Mathews Griner, Lesley A., primary, Martin, Scott E., primary, Odzorig, Taivan, primary, De, Soumita, primary, Ferrer, Marc, primary, Powers, Astin S., primary, Hewitt, Stephen M., primary, and Rudloff, Udo, primary

Published
2023
Full Text
View/download PDF

10. Table S7 from Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways

Author

Pham, Trang H., primary, Hagenbeek, Thijs J., primary, Lee, Ho-June, primary, Li, Jason, primary, Rose, Christopher M., primary, Lin, Eva, primary, Yu, Mamie, primary, Martin, Scott E., primary, Piskol, Robert, primary, Lacap, Jennifer A., primary, Sampath, Deepak, primary, Pham, Victoria C., primary, Modrusan, Zora, primary, Lill, Jennie R., primary, Klijn, Christiaan, primary, Malek, Shiva, primary, Chang, Matthew T., primary, and Dey, Anwesha, primary

Published
2023
Full Text
View/download PDF

11. Data from CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing Sarcoma

Author

Flores, Guillermo, primary, Everett, Joel H., primary, Boguslawski, Elissa A., primary, Oswald, Brandon M., primary, Madaj, Zachary B., primary, Beddows, Ian, primary, Dikalov, Sergey, primary, Adams, Marie, primary, Klumpp-Thomas, Carleen A., primary, Kitchen-Goosen, Susan M., primary, Martin, Scott E., primary, Caplen, Natasha J., primary, Helman, Lee J., primary, and Grohar, Patrick J., primary

Published
2023
Full Text
View/download PDF

12. Figure S1 from Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways

Author

Pham, Trang H., primary, Hagenbeek, Thijs J., primary, Lee, Ho-June, primary, Li, Jason, primary, Rose, Christopher M., primary, Lin, Eva, primary, Yu, Mamie, primary, Martin, Scott E., primary, Piskol, Robert, primary, Lacap, Jennifer A., primary, Sampath, Deepak, primary, Pham, Victoria C., primary, Modrusan, Zora, primary, Lill, Jennie R., primary, Klijn, Christiaan, primary, Malek, Shiva, primary, Chang, Matthew T., primary, and Dey, Anwesha, primary

Published
2023
Full Text
View/download PDF

14. Data from Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways

Author

Pham, Trang H., primary, Hagenbeek, Thijs J., primary, Lee, Ho-June, primary, Li, Jason, primary, Rose, Christopher M., primary, Lin, Eva, primary, Yu, Mamie, primary, Martin, Scott E., primary, Piskol, Robert, primary, Lacap, Jennifer A., primary, Sampath, Deepak, primary, Pham, Victoria C., primary, Modrusan, Zora, primary, Lill, Jennie R., primary, Klijn, Christiaan, primary, Malek, Shiva, primary, Chang, Matthew T., primary, and Dey, Anwesha, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Table S1 from CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing Sarcoma

Author

Flores, Guillermo, primary, Everett, Joel H., primary, Boguslawski, Elissa A., primary, Oswald, Brandon M., primary, Madaj, Zachary B., primary, Beddows, Ian, primary, Dikalov, Sergey, primary, Adams, Marie, primary, Klumpp-Thomas, Carleen A., primary, Kitchen-Goosen, Susan M., primary, Martin, Scott E., primary, Caplen, Natasha J., primary, Helman, Lee J., primary, and Grohar, Patrick J., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Data from CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing Sarcoma

Author

Flores, Guillermo, primary, Everett, Joel H., primary, Boguslawski, Elissa A., primary, Oswald, Brandon M., primary, Madaj, Zachary B., primary, Beddows, Ian, primary, Dikalov, Sergey, primary, Adams, Marie, primary, Klumpp-Thomas, Carleen A., primary, Kitchen-Goosen, Susan M., primary, Martin, Scott E., primary, Caplen, Natasha J., primary, Helman, Lee J., primary, and Grohar, Patrick J., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Data from Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer

Author

Saleh, Anthony D., primary, Cheng, Hui, primary, Martin, Scott E., primary, Si, Han, primary, Ormanoglu, Pinar, primary, Carlson, Sophie, primary, Clavijo, Paul E., primary, Yang, Xinping, primary, Das, Rita, primary, Cornelius, Shaleeka, primary, Couper, Jamie, primary, Chepeha, Douglas, primary, Danilova, Ludmila, primary, Harris, Thomas M., primary, Prystowsky, Michael B., primary, Childs, Geoffrey J., primary, Smith, Richard V., primary, Robertson, A. Gordon, primary, Jones, Steven J. M., primary, Cherniack, Andrew D., primary, Kim, Sang S., primary, Rait, Antonina, primary, Pirollo, Kathleen F., primary, Chang, Esther H., primary, Chen, Zhong, primary, and Van Waes, Carter, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figs S9-11 from ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer

Author

Vartanian, Steffan, primary, Lee, James, primary, Klijn, Christiaan, primary, Gnad, Florian, primary, Bagniewska, Maria, primary, Schaefer, Gabriele, primary, Zhang, Donglu, primary, Tan, Jenille, primary, Watson, Sara A., primary, Liu, Liling, primary, Chen, Honglin, primary, Liang, Yuxin, primary, Watanabe, Colin, primary, Cuellar, Trinna, primary, Kan, David, primary, Hartmaier, Ryan J., primary, Lau, Ted, primary, Costa, Michael R., primary, Martin, Scott E., primary, Merchant, Mark, primary, Haley, Benjamin, primary, and Stokoe, David, primary

Published
2023
Full Text
View/download PDF

25. Supplementary File from Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma

Author

Daemen, Anneleen, primary, Cooper, Jonathan E., primary, Myrta, Szymon, primary, Wongchenko, Matthew J., primary, Lin, Eva, primary, Long, Jason E., primary, Foreman, Oded, primary, Modrusan, Zora, primary, Tremayne, Jarrod R., primary, de la Cruz, Cecile C., primary, Merchant, Mark, primary, Martin, Scott E., primary, Yan, Yibing, primary, and Junttila, Melissa R., primary

Published
2023
Full Text
View/download PDF

26. Figure S1 from Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma

Author

Daemen, Anneleen, primary, Cooper, Jonathan E., primary, Myrta, Szymon, primary, Wongchenko, Matthew J., primary, Lin, Eva, primary, Long, Jason E., primary, Foreman, Oded, primary, Modrusan, Zora, primary, Tremayne, Jarrod R., primary, de la Cruz, Cecile C., primary, Merchant, Mark, primary, Martin, Scott E., primary, Yan, Yibing, primary, and Junttila, Melissa R., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Tables S1-4 from ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer

Author

Vartanian, Steffan, primary, Lee, James, primary, Klijn, Christiaan, primary, Gnad, Florian, primary, Bagniewska, Maria, primary, Schaefer, Gabriele, primary, Zhang, Donglu, primary, Tan, Jenille, primary, Watson, Sara A., primary, Liu, Liling, primary, Chen, Honglin, primary, Liang, Yuxin, primary, Watanabe, Colin, primary, Cuellar, Trinna, primary, Kan, David, primary, Hartmaier, Ryan J., primary, Lau, Ted, primary, Costa, Michael R., primary, Martin, Scott E., primary, Merchant, Mark, primary, Haley, Benjamin, primary, and Stokoe, David, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figs S7,8 from ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer

Author

Vartanian, Steffan, primary, Lee, James, primary, Klijn, Christiaan, primary, Gnad, Florian, primary, Bagniewska, Maria, primary, Schaefer, Gabriele, primary, Zhang, Donglu, primary, Tan, Jenille, primary, Watson, Sara A., primary, Liu, Liling, primary, Chen, Honglin, primary, Liang, Yuxin, primary, Watanabe, Colin, primary, Cuellar, Trinna, primary, Kan, David, primary, Hartmaier, Ryan J., primary, Lau, Ted, primary, Costa, Michael R., primary, Martin, Scott E., primary, Merchant, Mark, primary, Haley, Benjamin, primary, and Stokoe, David, primary

Published
2023
Full Text
View/download PDF

31. Supp Table S1, S3-8 from Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer

Author

Saleh, Anthony D., primary, Cheng, Hui, primary, Martin, Scott E., primary, Si, Han, primary, Ormanoglu, Pinar, primary, Carlson, Sophie, primary, Clavijo, Paul E., primary, Yang, Xinping, primary, Das, Rita, primary, Cornelius, Shaleeka, primary, Couper, Jamie, primary, Chepeha, Douglas, primary, Danilova, Ludmila, primary, Harris, Thomas M., primary, Prystowsky, Michael B., primary, Childs, Geoffrey J., primary, Smith, Richard V., primary, Robertson, A. Gordon, primary, Jones, Steven J. M., primary, Cherniack, Andrew D., primary, Kim, Sang S., primary, Rait, Antonina, primary, Pirollo, Kathleen F., primary, Chang, Esther H., primary, Chen, Zhong, primary, and Van Waes, Carter, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figs S1-4 from ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer

Author

Vartanian, Steffan, primary, Lee, James, primary, Klijn, Christiaan, primary, Gnad, Florian, primary, Bagniewska, Maria, primary, Schaefer, Gabriele, primary, Zhang, Donglu, primary, Tan, Jenille, primary, Watson, Sara A., primary, Liu, Liling, primary, Chen, Honglin, primary, Liang, Yuxin, primary, Watanabe, Colin, primary, Cuellar, Trinna, primary, Kan, David, primary, Hartmaier, Ryan J., primary, Lau, Ted, primary, Costa, Michael R., primary, Martin, Scott E., primary, Merchant, Mark, primary, Haley, Benjamin, primary, and Stokoe, David, primary

Published
2023
Full Text
View/download PDF

33. Data from ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer

Author

Vartanian, Steffan, primary, Lee, James, primary, Klijn, Christiaan, primary, Gnad, Florian, primary, Bagniewska, Maria, primary, Schaefer, Gabriele, primary, Zhang, Donglu, primary, Tan, Jenille, primary, Watson, Sara A., primary, Liu, Liling, primary, Chen, Honglin, primary, Liang, Yuxin, primary, Watanabe, Colin, primary, Cuellar, Trinna, primary, Kan, David, primary, Hartmaier, Ryan J., primary, Lau, Ted, primary, Costa, Michael R., primary, Martin, Scott E., primary, Merchant, Mark, primary, Haley, Benjamin, primary, and Stokoe, David, primary

Published
2023
Full Text
View/download PDF

38. Data from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

Author

Jossé, Rozenn, primary, Martin, Scott E., primary, Guha, Rajarshi, primary, Ormanoglu, Pinar, primary, Pfister, Thomas D., primary, Reaper, Philip M., primary, Barnes, Christopher S., primary, Jones, Julie, primary, Charlton, Peter, primary, Pollard, John R., primary, Morris, Joel, primary, Doroshow, James H., primary, and Pommier, Yves, primary

Published
2023
Full Text
View/download PDF

39. Supplemental Table S1 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

Author

Jossé, Rozenn, primary, Martin, Scott E., primary, Guha, Rajarshi, primary, Ormanoglu, Pinar, primary, Pfister, Thomas D., primary, Reaper, Philip M., primary, Barnes, Christopher S., primary, Jones, Julie, primary, Charlton, Peter, primary, Pollard, John R., primary, Morris, Joel, primary, Doroshow, James H., primary, and Pommier, Yves, primary

Published
2023
Full Text
View/download PDF

43. Supplemental Figure S3 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

Author

Jossé, Rozenn, primary, Martin, Scott E., primary, Guha, Rajarshi, primary, Ormanoglu, Pinar, primary, Pfister, Thomas D., primary, Reaper, Philip M., primary, Barnes, Christopher S., primary, Jones, Julie, primary, Charlton, Peter, primary, Pollard, John R., primary, Morris, Joel, primary, Doroshow, James H., primary, and Pommier, Yves, primary

Published
2023
Full Text
View/download PDF

47. Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling

Author

Li, Dandan, primary, Miermont, Anne M., additional, Sable, Rushikesh, additional, Quadri, Humair S., additional, Mathews Griner, Lesley A., additional, Martin, Scott E., additional, Odzorig, Taivan, additional, De, Soumita, additional, Ferrer, Marc, additional, Powers, Astin S., additional, Hewitt, Stephen M., additional, and Rudloff, Udo, additional

Published
2023
Full Text
View/download PDF

48. USP7 small-molecule inhibitors interfere with ubiquitin binding

Author

Kategaya, Lorna, Di Lello, Paola, Rougé, Lionel, Pastor, Richard, Clark, Kevin R., Drummond, Jason, Kleinheinz, Tracy, Lin, Eva, Upton, John-Paul, Prakash, Sumit, Heideker, Johanna, McCleland, Mark, Ritorto, Maria Stella, Alessi, Dario R., Trost, Matthias, Bainbridge, Travis W., Kwok, Michael C. M., Ma, Taylur P., Stiffler, Zachary, Brasher, Bradley, Tang, Yinyan, Jaishankar, Priyadarshini, Hearn, Brian R., Renslo, Adam R., Arkin, Michelle R., Cohen, Frederick, Yu, Kebing, Peale, Frank, Gnad, Florian, Chang, Matthew T., Klijn, Christiaan, Blackwood, Elizabeth, Martin, Scott E., Forrest, William F., Ernst, James A., Ndubaku, Chudi, Wang, Xiaojing, Beresini, Maureen H., Tsui, Vickie, Schwerdtfeger, Carsten, Blake, Robert A., Murray, Jeremy, Maurer, Till, and Wertz, Ingrid E.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results